Healthcare

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on innovations that leverage artificial intelligence (AI) and machine learning (ML) algorithms for diagnostics and drug discovery applications. Innovations around AI and ML augmented diagnostics have been highlighted, which include molecular diagnostics,...

06 Jan 2022  |  Global  |  Mega Trends

Global Diabetes Devices and Services Growth Opportunities

Growth Strategies in an Increasingly Competitive and Digitalized Environment

Infographics

×

The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are def...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes digital health innovations such as digital biomarkers for advanced diagnosis and treatment decisions, AI-based diagnosis and monitoring devices, AI-based digital path...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) presents growth opportunities in microbiome therapeutics, AI-enabled diagnostics, advanced wound healing, DNA storage, single cell analysis, and multi-omics platforms. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the ...

The global pharmaceutical industry is witnessing dynamic trends following the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond. It addresses the impact of innovative modalities, technologies, ...

The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countr...

With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes wound care solutions, such as composite wound dressing film, anti-bacterial dendritic hydrogels for wound care, and anti-bacterial embedded nanofibrous wound dressing...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers innovations on AI augmented diagnostics for cancer and infectious diseases. The increase in clinical utility of liquid biopsies and other diagnostic assays, which is driven by AI has been discussed. The TOE issue also highlights developments in enabling t...